Search research articles
Contact Us
Filters
Showing results (231-240 of 917) with videos related to
Page
of 92
Sort By:
Diagnostic Microbiology and Infectious Disease
|
January 9, 2001
In vitro activity of gemifloxacin against contemporary clinical bacterial isolates from eleven North American medical centers, and assessment of disk diffusion test interpretive criteria
P C Fuchs, A L Barry, S D Brown
Antimicrobial Agents and Chemotherapy
|
May 17, 2001
In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers
A L Barry, P C Fuchs, S D Brown
Physical Review Letters
|
April 6, 2001
Probing the nuclear equation of state by K+ production in heavy-ion collisions
C Fuchs, A Faessler, E Zabrodin, et al.
Antimicrobial Agents and Chemotherapy
|
April 17, 2001
Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media
A L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy
|
January 18, 2002
Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory Standards
Peter C Fuchs, Arthur L Barry, Steven D Brown
The Journal of Antimicrobial Chemotherapy
|
January 30, 2002
In vitro activity of telithromycin against Streptococcus pneumoniae resistant to other antibiotics, including cefotaxime
Peter C Fuchs, Arthur L Barry, Steven D Brown
Antimicrobial Agents and Chemotherapy
|
May 1, 1990
In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040
P C Fuchs, R N Jones, A L Barry
The Journal of Antimicrobial Chemotherapy
|
June 26, 1999
In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests
P C Fuchs, A L Barry, S D Brown
The Journal of Antimicrobial Chemotherapy
|
February 28, 2002
In vitro bactericidal activity of daptomycin against staphylococci
Peter C Fuchs, Arthur L Barry, Steven D Brown
Antimicrobial Agents and Chemotherapy
|
July 1, 1996
Prevalence of resistance to three fluoroquinolones: assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility. AST Surveillance Group
P C Fuchs, A L Barry, S D Brown
Page
of 92
Search research articles
Search
Showing results (231-240 of 917) with videos related to
Sort By:
Page
of 92
Diagnostic Microbiology and Infectious Disease
|
January 9, 2001
In vitro activity of gemifloxacin against contemporary clinical bacterial isolates from eleven North American medical centers, and assessment of disk diffusion test interpretive criteria
P C Fuchs, A L Barry, S D Brown
Antimicrobial Agents and Chemotherapy
|
May 17, 2001
In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers
A L Barry, P C Fuchs, S D Brown
Physical Review Letters
|
April 6, 2001
Probing the nuclear equation of state by K+ production in heavy-ion collisions
C Fuchs, A Faessler, E Zabrodin, et al.
Antimicrobial Agents and Chemotherapy
|
April 17, 2001
Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media
A L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy
|
January 18, 2002
Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory Standards
Peter C Fuchs, Arthur L Barry, Steven D Brown
The Journal of Antimicrobial Chemotherapy
|
January 30, 2002
In vitro activity of telithromycin against Streptococcus pneumoniae resistant to other antibiotics, including cefotaxime
Peter C Fuchs, Arthur L Barry, Steven D Brown
Antimicrobial Agents and Chemotherapy
|
May 1, 1990
In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040
P C Fuchs, R N Jones, A L Barry
The Journal of Antimicrobial Chemotherapy
|
June 26, 1999
In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests
P C Fuchs, A L Barry, S D Brown
The Journal of Antimicrobial Chemotherapy
|
February 28, 2002
In vitro bactericidal activity of daptomycin against staphylococci
Peter C Fuchs, Arthur L Barry, Steven D Brown
Antimicrobial Agents and Chemotherapy
|
July 1, 1996
Prevalence of resistance to three fluoroquinolones: assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility. AST Surveillance Group
P C Fuchs, A L Barry, S D Brown
Page
of 92